Stoke Therapeutics Inc. (STOK) Social Stream



Stoke Therapeutics Inc. (STOK): $11.44

0.17 (+1.51%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add STOK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#146 of 334

in industry

STOKE THERAPEUTICS INC (STOK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering STOKE THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $76 $35 $57.857 $5.26 999.94%
2021-11-12 6 $76 $35 $57.571 $5.26 994.51%
2021-11-22 6 $76 $35 $57.571 $5.26 994.51%
2021-12-03 8 $76 $35 $54.428 $5.26 934.75%
2022-02-01 8 $76 $35 $53.875 $5.26 924.24%
2022-03-11 8 $70 $35 $50.714 $5.26 864.14%
2022-03-14 8 $70 $32 $49.333 $5.26 837.89%
2022-03-17 8 $70 $32 $48.428 $5.26 820.68%
2022-03-21 8 $70 $32 $45 $5.26 755.51%
2022-05-10 8 $70 $32 $48.285 $5.26 817.97%
2022-05-11 8 $70 $33 $47.714 $5.26 807.11%
2022-05-17 8 $70 $33 $49.5 $5.26 841.06%
2022-05-19 7 $70 $33 $49.5 $5.26 841.06%
2022-05-26 7 $70 $33 $44.5 $5.26 746.01%
2022-08-08 7 $70 $24 $42.166 $5.26 701.63%
2022-08-09 8 $70 $24 $42.166 $5.26 701.63%
2022-08-13 8 $70 $24 $43.285 $5.26 722.91%
2022-09-17 9 $70 $24 $43 $5.26 717.49%
2022-10-24 8 $70 $24 $41.375 $5.26 686.6%
2022-11-14 8 $70 $22 $41.125 $5.26 681.84%
2022-11-15 8 $70 $20 $34.5 $5.26 555.89%
2022-12-05 9 $40 $20 $30.125 $5.26 472.72%
2023-01-03 9 $40 $20 $29.375 $5.26 458.46%
2023-02-08 9 $40 $9 $27.75 $5.26 427.57%
2023-03-07 8 $40 $9 $27.75 $5.26 427.57%
2023-03-08 8 $40 $9 $26.75 $5.26 408.56%
2023-04-20 8 $35 $9 $24.428 $5.26 364.41%
2023-04-26 9 $35 $9 $24.375 $5.26 363.4%
2023-05-05 9 $35 $12 $24.75 $5.26 370.53%
2023-05-09 9 $35 $12 $23.771 $5.26 351.92%
2023-06-06 9 $35 $12 $24.396 $5.26 363.8%
2023-06-29 8 $35 $12 $24 $5.26 356.27%
2023-07-25 8 $35 $12 $24.714 $5.26 369.85%
2023-08-08 8 $35 $12 $21.714 $5.26 312.81%
2023-08-14 8 $35 $12 $20.428 $5.26 288.37%
2023-11-08 9 $35 $4.2 $18.421 $5.26 250.21%
2023-11-20 9 $35 $4.2 $16.647 $5.26 216.48%

The Trend in the Analyst Price Target


Over the past 41 weeks, STOK's average price target has gone down $11.1.

STOK reports an average of 203.16% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-08 9 35 9 24.857 9.12 172.55%
2023-05-08 9 35 12 23.771 12.04 97.43%
2023-06-06 9 35 12 24.024 13.20 82%
2023-06-06 8 35 12 24.024 13.20 82%
2023-08-08 8 35 9 20.000 5.55 260.36%

STOK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.78 5 1 3 0 0 9

The Trend in the Broker Recommendations


STOK's average broker recommendation rating worsened by 0.66 over the prior 14 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, STOKE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 4803.19% of them.
  • STOK has a lower variance in analysts' estimates than -4307.36% of all US stocks.
  • In the context of stocks in the mid market cap category, STOKE THERAPEUTICS INC's average analyst price target is higher than 2470.63% of them.
  • STOK has a higher number of analysts covering the stock than 2818.21% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to STOKE THERAPEUTICS INC are PTGX, XENE, and CMRX.

Is STOK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!